Nonalcoholic fatty liver disease and cardiovascular disease
about
Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateRhizoma Coptidis: A Potential Cardiovascular Protective AgentNonalcoholic fatty liver disease - A multisystem disease?Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewBenefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisNoninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesEffects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis.Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkersAssociation of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal womenCurrent Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis.Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet.Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolomeAssessment of Subclinical Myocardial Changes in Non-Alcoholic Fatty Liver Disease: A Case-Control Study Using Speckle Tracking Echocardiography
P2860
Q26781753-C9BD7BFE-3612-4E1D-B78C-37D88CF09259Q26997059-AA476A34-25F6-4EC9-97FB-6B34F8A8CEECQ28067054-C2901EA8-2E2B-4DB3-A434-F1ECC1CE74F2Q28079077-2922F6FE-978A-440D-9338-2BAE77D2B86DQ28079821-DD800DBE-CD5E-4E58-8F7B-AF251BF23385Q28553482-ABE5609A-078A-41A1-867A-CC96F1F741C4Q30355082-0992F6A8-A5B8-4E72-B44F-B3F842584611Q33573638-904E4846-2597-4A18-A192-42B554D1A71AQ33574490-B4417D3B-E5B1-4495-BFD2-C777C24F6DCDQ34728267-6A27E34B-91C1-4556-9066-8D3D6FE7D026Q35737798-863EA5C3-FC9D-42BC-B7A9-EA165ED56988Q35841934-4E027614-4DBF-4E43-AFA4-A31A7DE3959CQ36712914-E9A37B0D-8603-4D67-8437-B96794A10C3DQ36905761-E233DE2D-9E4E-419F-BA71-86CD5C18AF22Q37107217-F4D38FAE-43AB-4744-BC8B-D75A5E038035Q37517243-418DD7F4-BA7C-4FF4-8CA0-6BCCA8997677Q40064196-F1559D35-08A6-4A99-907E-EAD78EE3D8AAQ40542879-8F94F88F-1801-40E9-8042-5208068C80DCQ40893622-3C5EF48B-68EE-4908-9A43-B420CF7D756CQ40959440-FA6EE88A-6A0B-42E2-BDC6-1C25D6F5E6E9Q41549697-80249F7C-B0BA-4158-B21F-A7D1457E1BB5Q41706840-07FC7827-3FB2-4AE9-A9EE-869B78A8DDE6Q45305677-575CAC86-725B-4EB4-9E34-C803A7D05DFCQ46424148-D95FC592-3851-462D-AB8F-3F214C86F5DCQ51264387-84D011E7-6733-43DD-9C5E-5D6AA290C925Q55024308-0F7F9057-10D5-4248-A5E2-786CA74D03FFQ55323878-16C82151-50F9-4BB2-ACCB-6D6504F7605CQ58705829-45D9E59B-2047-4AA9-AB7C-B1635E07FFECQ58776380-A8B62E5C-00DB-4EDD-9FB7-8151E8E947B8
P2860
Nonalcoholic fatty liver disease and cardiovascular disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Nonalcoholic fatty liver disease and cardiovascular disease
@ast
Nonalcoholic fatty liver disease and cardiovascular disease
@en
type
label
Nonalcoholic fatty liver disease and cardiovascular disease
@ast
Nonalcoholic fatty liver disease and cardiovascular disease
@en
prefLabel
Nonalcoholic fatty liver disease and cardiovascular disease
@ast
Nonalcoholic fatty liver disease and cardiovascular disease
@en
P2860
P356
P1476
Nonalcoholic fatty liver disease and cardiovascular disease
@en
P2093
P2860
P304
P356
10.3748/WJG.V20.I26.8407
P407
P577
2014-07-01T00:00:00Z